KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Research & Development (2016 - 2025)

Historic Research & Development for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $4.2 billion.

  • Merck's Research & Development fell 2777.21% to $4.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 billion, marking a year-over-year decrease of 2825.81%. This contributed to the annual value of $17.9 billion for FY2024, which is 4124.66% down from last year.
  • According to the latest figures from Q3 2025, Merck's Research & Development is $4.2 billion, which was down 2777.21% from $4.0 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Research & Development peaked at $13.3 billion during Q2 2023, and registered a low of $2.4 billion during Q1 2021.
  • Moreover, its 5-year median value for Research & Development was $4.0 billion (2024), whereas its average is $4.5 billion.
  • In the last 5 years, Merck's Research & Development surged by 37609.01% in 2023 and then crashed by 7372.57% in 2024.
  • Merck's Research & Development (Quarter) stood at $3.1 billion in 2021, then grew by 23.04% to $3.8 billion in 2022, then soared by 155.02% to $9.6 billion in 2023, then plummeted by 52.38% to $4.6 billion in 2024, then fell by 7.64% to $4.2 billion in 2025.
  • Its Research & Development stands at $4.2 billion for Q3 2025, versus $4.0 billion for Q2 2025 and $3.6 billion for Q1 2025.